Cryopreservation
11
3
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Cryopreservation of Ovarian Tissue: Reimplantation Rate and Effects on Ovarian Function
Fertility and Ovarian Reserve in Female Childhood Cancer Survivors
Effect of Long-time Human Sperm Storage in Liquid Nitrogen on Semen Parameters
Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ?
Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma
Priority to Cryopreservation Strategy (PCS) in IVF-ICSI Cycles
Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.
Testicular Tissue Cryopreservation for Fertility Preservation in Male Patients Facing Infertility-causing Diseases or Treatment Regimens
Hypotaurine Supplementation Benefits in Cryopreservation
The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation
Cryosurvival of Embryos From Dysmorphic Oocytes